Ruta Gupta

Professor Ruta Gupta is a Clinical Professor at the Central Clinical School, University of Sydney, specializing in pathology and oncology. Her research focuses on head and neck oncology, cutaneous squamous cell carcinoma, oral malignancies, and salivary gland tumors, with a strong emphasis on molecular mechanisms, surgical outcomes, and diagnostic protocols. She advises current research student Aki and collaborates extensively with multidisciplinary teams globally. Her work includes advancing pathology reporting standards and addressing gender inequity in healthcare professions. She is affiliated with the university's pathology department and has contributed to numerous clinical studies, including those evaluating novel staging systems and surgical techniques for cancer management.

• Education: Not explicitly listed in the text but inferred through her academic role and publications.
• Clinical Specialty: Pathology, with a focus on oncological and molecular diagnostics.

Her research interests prioritize understanding tumor microenvironments, immune responses in cancers, and improving clinical staging protocols. Recent studies emphasize the prognostic value of nodal status, surgical margins, and molecular markers (e.g., MYB RNA, PD-L1) in head and neck cancers. Collaborations involve international groups such as the International Collaboration on Cancer Reporting, aiming to standardize diagnostic criteria and terminology.

Her publications span oncology, pathology, and surgical science, exploring topics like lymph node metastasis, perineural invasion, and the impact of age/gender on cancer outcomes. She has pioneered studies on novel tumor classifications (e.g., N-classification for salivary gland cancers) and contributed to debates on cancer staging for rare tumors. Her work also highlights emerging technologies, such as bioreactor systems for bone regeneration and AI-driven healthcare analytics.

• Scientific Contributions: Over 100 peer-reviewed articles, focusing on clinical and molecular oncology.

Advising and grants are centered on her student Aki and collaborative projects, though specific grant details are not mentioned. She actively participates in initiatives addressing gender equity in pathology and improving diagnostic practices in resource-limited settings.

Her research teams include experts in surgical oncology, molecular pathology, and immunology, with labs focused on translational cancer research and clinical trial development (e.g., De-Squamate study for PD-1 inhibitors in cutaneous SCC).